These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 23358478)
1. Myocardial radionuclide imaging in patients with hypertrophic cardiomyopathy. Cai M; Tian YQ; He ZX Nucl Med Commun; 2013 Apr; 34(4):298-305. PubMed ID: 23358478 [TBL] [Abstract][Full Text] [Related]
2. Myocardial condition after transcoronary ablation predicts the curative effect in patients with hypertrophic obstructive cardiomyopathy. Jiang TY; Wu XS; Han ZH; Jia CQ; Mi HZ; Gao YC; Zhang XL Chin Med J (Engl); 2006 Feb; 119(3):246-9. PubMed ID: 16537015 [No Abstract] [Full Text] [Related]
3. Use of cardiac magnetic resonance imaging for alcohol septal ablation in hypertrophic obstructive cardiomyopathy. Batton K; Moussa I; Blackshear J; Mergo P; Austin C; Shapiro B Acute Card Care; 2013 Jun; 15(2):44-6. PubMed ID: 23663012 [TBL] [Abstract][Full Text] [Related]
4. Changes in the left ventricular outflow tract after transcoronary ablation of septal hypertrophy (TASH) for hypertrophic obstructive cardiomyopathy as assessed by transoesophageal echocardiography and by measuring myocardial glucose utilization and perfusion. Kuhn H; Gietzen FH; Schäfers M; Freick M; Gockel B; Strunk-Müller C; Jachmann E; Schober O Eur Heart J; 1999 Dec; 20(24):1808-17. PubMed ID: 10581139 [TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance imaging in familial hypertrophic cardiomyopathy associated with abnormal thallium perfusion and cardiac enzymes. Nishimura T; Nagata S; Sakakibara H Jpn Circ J; 1988 May; 52(5):395-400. PubMed ID: 3411762 [TBL] [Abstract][Full Text] [Related]
6. Myocardial perfusion and metabolism after transcoronary ablation of septum hypertrophy (TASH) in hypertrophic obstructive cardiomyopathy. Lerch H; Schäfers M; Gietzen F; Schäfers K; Kuwert T; Kuhn H; Schober O Nuklearmedizin; 1997 Sep; 36(6):218-22. PubMed ID: 9380540 [TBL] [Abstract][Full Text] [Related]
7. Alcohol septal ablation in hypertrophic cardiomyopathy: an opportunity to be taken. Gimeno JR; Tomé MT; McKenna WJ Rev Esp Cardiol (Engl Ed); 2012 Apr; 65(4):314-8. PubMed ID: 22381943 [No Abstract] [Full Text] [Related]
8. Role of cardiac computed tomography in planning and evaluating percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy. Okayama S; Uemura S; Soeda T; Horii M; Saito Y J Cardiovasc Comput Tomogr; 2010; 4(1):62-5. PubMed ID: 19914881 [TBL] [Abstract][Full Text] [Related]
9. Continuing improvement of cardiac sympathetic activity on I-123 MIBG scintigraphy in a patient with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation. Okayama S; Uemura S; Horii M; Kawata H; Saito Y J Nucl Cardiol; 2008; 15(5):e31-4. PubMed ID: 18761260 [No Abstract] [Full Text] [Related]
10. [Asymmetric septal hypertrophy of sporadic form with abnormal thallium perfusion and myocardial enzymes]. Nagata S; Minamikawa T; Park YD; Nishimura T; Yutani C; Ohmori F; Sakakibara H; Nimura Y J Cardiogr Suppl; 1986; (9):57-65. PubMed ID: 3760618 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of left ventricular myocardial perfusion and function using gated SPECT in patients with hypertrophic obstruction cardiomyopathy following percutaneous transluminal septal myocardial ablation. Zhang L; Liu R; Qiao SB; Sun XX; He ZX; Tian YQ Nucl Med Commun; 2014 Jul; 35(7):762-6. PubMed ID: 24681766 [TBL] [Abstract][Full Text] [Related]
12. "Protruding Myocardium" as a Target for Percutaneous Transluminal Septal Myocardial Ablation in a Case of Hypertrophic Obstructive Cardiomyopathy. Maekawa Y; Akita K; Tsuruta H; Yashima F; Kimura M; Yamada Y; Kawakami T; Kanazawa H; Hayashida K; Yuasa S; Murata M; Jinzaki M; Fukuda K JACC Cardiovasc Interv; 2015 Oct; 8(12):e201-2. PubMed ID: 26493263 [No Abstract] [Full Text] [Related]
13. Clinical use of metaiodobenzylguanidine imaging in cardiology. Merlet P; Piot O; Dubois-Randé JL; Loisance D; Castaigne A; Syrota A Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):29-39. PubMed ID: 9002746 [TBL] [Abstract][Full Text] [Related]
14. [Dilated cardiomyopathy. Role of radioisotope technics]. Cuocolo A; McCarthy KE; Salvatore M Radiol Med; 1988 May; 75(5):439-45. PubMed ID: 3163814 [TBL] [Abstract][Full Text] [Related]